Rheumatoid Arthritis. Rheumatoid arthritis with rheumatoid factor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Rheumatoid arthritis patients (based on ACR criteria) At least 3 months after the diagnosis of RA. At least 4 swollen joints which were in a stable status for at least 1 month, on MTX and prednisolone
Exclusion criteria
Exclusion criteria: Drug reaction and hypersensitivity patient dissatisfaction consumption of probiotic oral or medical in the last 2 weeks IBD intestinal perforation creatinine clearance by using the CKD-EPI equation of less than 40 mL/min per 1.73 m2 aspartate and alanine aminotransferase levels greater than twice the upper limit of normal active or recent hepatitis or cirrhosis plan for surgery in the next 3 months thyroid disorders Cushing's disease or syndrome malignant tumors, inadequately controlled diabetes mellitus or arterial hypertension serious infections, serious cardiac or respiratory diseases, leukopenia or thrombocytopenia, inadequate contraception, pregnancy or a plan for it in the next 3 months, breastfeeding, osteoporosis, use of cytotoxic or immunosuppressive drugs for 3 months before inclusion, current or past substance abuse (including tobacco) or alcohol use greater than 2 U/d and psychological illnesses or intellectual disorders that would preclude adherence to the study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of disease activity. Timepoint: At the beginning of the study and 3 months after starting the drug. Method of measurement: Physical examination for the number of tender joint (T1) and swellen j (S1) and blood tests (ESR, CRP, ALT, Cr), calculate DAS28 according to ESR, Tender Joint, Sowllen joint and VAS dat. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences